Surfing the MASH Tsunami
Driving the Discussion in Fatty Liver Disease. Join hepatology researcher and Key Opinion Leader Jörn Schattenberg, Liver Wellness Advocate Louise Campbell, and Forecasting and Pricing Guru Roger Green and a global group of Key Opinion Leaders and patient advocates as they discuss key issues in Fatty Liver disease, including epidemiology, drug development, clinical pathways, non-invasive testing, health economics and regulatory issues, from their own unique perspectives on the Surfing the MASH Tsunami podcast. #MASH #MAFLD #FattyLiver #livertwitter #AASLD #GlobalLiver #NoNASH #EASL
- Update frequency
- every day
- Average duration
- 26 minutes
- Episodes
- 1069
- Years Active
- 2020 - 2025
S5 - E21.1 - The Updated MASLD CPG: Introductions
Two of the co-authors of the upgraded MASLD Clinical Practice Guidelines, Elisabetta Bugianesi and Frank Tacke join Louise Campbell and Roger Green to discuss the guidelines.
The theme…
S5 - E21 - Reviewing The Updated ESL-EASD-EASO MASLD Clinical Practice Guidelines
00:00:00 - Surf's Up: Season 5 Episode 21
One important session at the EASL Congress 2024 involved the presentation of the new MASLD Clinical Practice Guidelines. CPG co-authors Elisabe…
S5 - E20.6 - From the Vault: FGF-21s and "Twin-cretins" At EASL Congress 2023
In this conversation from July 2023, Stephen Harrison, Jörn Schattenberg and Roger Green discuss the implications of presentations on the FGF-21 agent efruxifermin and the dual GLP/gluc…
S5 - E20.5 - Drug Development Highlights From EASL Congress 2024: Denifenstat, SPECIAL and Other Stories
Mazen Noureddin and Naim Alkhouri join Jörn Schattenberg and Roger Green to discuss some of the other major drug development stories from the EASL Congress 2024, with special focus on d…
S5 - E20.4 - Drug Development Highlights From EASL Congress 2024: Are FGF-21s Induction Therapy or a "MASH Cure"?
Mazen Noureddin and Naim Alkhouri join Jörn Schattenberg and Roger Green to focus on the role FGF-21s will play in long-term advanced fibrosis treatment: induction or long-term therapy.…
S5 - E20.3 - Drug Development Highlights From EASL Congress 2024: "Twin-cretins" and efruxifermin
Naim Alkhouri and Mazen Noureddin join Jörn Schattenberg and Roger Green to discuss issues regarding incretin agonists and results from the efruxiermin late-breaker at the EASL Congress…
S5 - E20.2 - Drug Development Highlights From EASL Congress 2024: Tirzepatidate and other "Twin-cretins"
Mazen Noureddin and Naim Alkhouri join Jörn Schattenberg and Roger Green to discuss the tirzepatide late-breaker at the EASL Congress 2024 and other "Twin-cretins," all of which are GLP…
S5 - E20.1 - Drug Development Highlights From EASL Congress 2024: Resmetirom
Naim Alkhouri and Mazen Noureddin join Jörn Schattenberg and Roger Green to discuss some of the new research on resmetirom at the EASL Congress 2024.
Mazen begins this discussion by cove…
S5 - E20 - Lessons From EASL Congress 2024: Exciting Advances in Drug Development
00:00:00 Surf's Up, Season 5 Episode 20
Naim Alkhouri and Mazen Noureddin join co-hosts Jörn Schattenberg and Roger Green to discuss major drug development stories from the EASL Congress…
EASL Congress 2024: Interviews From A Seminal Meeting For MASLD & MASH
00:00:00 - Surf's Up: Season 5 Episode 19
During EASL Congress 2024, US-based Roger Green, conducted interviews with Mike Betel, Louise Campbell (twice) and Sven Francque from Milano. Th…
S5 - E18.5 - How Listeners Can Support HOPE, A Unique Support Community For People Who Have Harmed Their Bodies Through Alcohol Use Disorder
In this final conversation, Sober Livers leaders Jenn Jones and Beth Lehman share what they hope listeners will take from this discussion of HOPE (Healing Others with Peers and Educatio…
S5 - E18.4 - The Future Of HOPE: Expanding the Support Community for Patients Who Have Harmed Their Bodies Through Alcohol Use Disorder
Sober Livers leaders Jenn Jones and Beth Lehman join Roger Green to discuss HOPE, their new support community for people who have harmed themselves through AUD (Alcohol Use Disorder). T…
S5 - E18.3 - Specific Support Elements HOPE Provides For People Who Have Harmed Themselves Due To Alcohol Use Disorder
In this conversation, Society of Sober LIvers leaders Jenn Jones and Beth Lehman describe the HOPE (Healing Others with Peers and Education) program. They go on to discuss why version …
S5 - E18.2 - Why People Who Have Harmed Themselves Through Alcohol Use Disorder Need HOPE
This conversation focuses on the target population of patients with AUD (Alcohol Use Disorder) with decompensated cirrhosis and asks why this group needs a support community like HOPE (…
S5 - E18.1 - Introducing HOPE, A Project For People Who Have Harmed Their Bodies Through Alcohol Use DIsorder
This conversation re-introduces us to Sober Livers Founder/Visionary Jenn Jones and introduces us to Beth Lehman, Principal Strategic Advisor to Sober Livers and HOPE, a multi-element p…
S5 - E18 - Introducing HOPE, a support program for patients living with the effects of ALD and cirrhosis
Roger Green is joined by Sober Livers Founder/Visionary Jenn Jones and Principal Strategic Advisor Beth Lehman to discuss HOPE, a support program launching June 11 for people who have h…
S5 - E17.6 - From The Vault: Looking Back At The EASL Congress 2023 Preview & Program Design
This week's Vault looks back to the EASL Congress 2023 and includes Aleksander Krag, Sven Francque and all three surfers: Jörn Schattenberg, Louise Campbell and Roger Green. The focus o…
S5 - E17.5 - Previewing EASL Congress 2024: Focusing On MASLD Drug Development
This final conversation from SurfingMASH's EASL Congress 2024 preview includes two final papers, one covering MASLD drug development, and a diverse set of answers to Roger Green's closi…
S5 - E17.4 - Previewing EASL Congress 2024: Is Big Data The Future Of MASLD?
This conversation revolves largely around two Big Data presentations Hannes Hagstrom's team is sharing at the EASL Congress. Every other panelist has at least one meaningful comment to …
S5 - E17.3 - Previewing EASL Congress 2024: Jörn Schattenberg Joins The MASLD Conversation
This conversation starts with Jörn Schattenberg joining the conversation. The main points are two abstracts, one reviewed by Jörn and the other by Aleksander Krag.
As Hannes finishes di…